在意大利罗马一家三级医院呼吸道病原体的流行率和抗菌素耐药性的时间趋势:回顾性分析 (2018-2023)
Fabio Ingravalle1, Massimo Maurici1, Antonio Vinci1
1Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.
抗菌素耐药性正在上升,Acinetobacter baumannii和Klebsiella pneumoniae的流行和耐药性趋势令人担忧. 持续监测对于有效的治疗和感染控制至关重要.
科学领域:
- 医学微生物学 医学微生物学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 抗菌素耐药性 (AMR) 构成了全球健康的重大威胁.
- 了解病原体动态对于临床管理和抗生素管理至关重要.
研究的目的:
- 分析呼吸道微生物流行率和抗生素耐药性的纵向趋势.
- 评估从2018年到2023年的病原体耐药性模式的变化.
主要方法:
- 对呼吸道微生物分离物的回顾性观察研究.
- 使用WHOnet软件分析了超过54,000个微生物/药物关联.
- 使用皮尔森相关性和线性回归的时间趋势分析.
主要成果:
- Acinetobacter baumannii表现出很高的流行率和多药性耐药性.
- 克莱布西拉肺炎对多种抗生素的耐药性趋势越来越大.
- 包括非白菌 (Candida) 种类在内的真菌,包括约20%具有内在醇耐药性的分离物.
结论:
- 微生物的流行率和抗菌素耐药性模式是动态的.
- 持续的微生物监测对于优化治疗和感染控制至关重要.
更多相关视频
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
相关概念视频
Development of Antibiotic Resistance
Antimicrobial Effectiveness
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
